New blood test parameters for diagnosing hereditary spherocytosis
Part of Blood & lymphatic, Genetic & congenital clinical trials.
This study looks at new ways to use routine blood test results to help diagnose hereditary spherocytosis, a condition where red blood cells are fragile. The goal is to make diagnosis easier and more accurate for children.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must be between 1 month and 18 years old.
- Your child must either have been diagnosed with hereditary spherocytosis, or be a healthy child without it.
- Your child must have had a recent complete blood count (CBC) and reticulocyte count.
- A parent or guardian must sign a consent form.
- Your child must not have had a blood transfusion recently, and their blood sample must be good enough for testing.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This research study helps doctors identify the genetic reason why some people have hemolytic anemia (a condition where red blood cells break down too quickly). Researchers will study patients with this condition and their family members to understand the underlying cause and potentially improve diagnosis and treatment.
This trial aims to improve how doctors diagnose rare inherited anemias, including sickle cell disease and other conditions that destroy red blood cells. It may help if you have a confirmed or suspected diagnosis but need more clarity through advanced testing.
This study tests whether giving red blood cells matched to your child’s RH (a blood marker) can improve safety and fit for people with sickle cell disease who need regular transfusions. It may help reduce mismatches by using blood units selected to match the child’s blood type more closely.
This study looks at blood cells in people with sickle cell disease and is done to better understand the disease. If you join, researchers will likely take a blood sample to see how your cells are working.
This trial studies the genes of people with a rare type of inherited anemia called congenital sideroblastic anemia, where the body has trouble making healthy red blood cells. It aims to find new genetic causes by looking at genes involved with the cell's energy centers (mitochondria).
This trial tests a special way of preparing red blood cells for transfusion to see if it can help people with sickle cell anemia. If you already get regular transfusions, this study might offer a new option that could reduce complications.
Hear when a new Hereditary Spherocytosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.